loader from loading.io

History of Neurology - Augusta Dejerine-Klumpke

Neurology Minute

Release Date: 01/31/2024

Post-Traumatic Headache in Children and Genetic Risk of Migraine show art Post-Traumatic Headache in Children and Genetic Risk of Migraine

Neurology Minute

Dr. Jessica Ailani and Dr. Serena Orr discuss the genetic risk of migraine and post-traumatic headache in children.  Show citation:  Orr SL, Hershey AD, Kurowski BG, et al. Post-Traumatic Headache in Children and Genetic Risk of Migraine: An Observational Cohort Study. Neurol Genet. 2026;12(2):e200371. Published 2026 Apr 1. doi: 

info_outline
Efficacy and Safety of Cemdisiran siRNA in Myasthenia Gravis show art Efficacy and Safety of Cemdisiran siRNA in Myasthenia Gravis

Neurology Minute

Dr. Aaron S. Zelikovich discusses the phase 3 NIMBLE trial of cemdisiran, an siRNA targeting complement component 5, for the treatment of generalized myasthenia gravis.  Show citation:  Vu T, Habib AA, Jacob S, et al. Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 2026;407(10540):1712-1725. doi: 

info_outline
Negative Myoclonus show art Negative Myoclonus

Neurology Minute

Dr. Zohaib Siddiqi shares clinical pearls on negative myoclonus. 

info_outline
An Update on Troriluzole show art An Update on Troriluzole

Neurology Minute

Dr. Margarita Fedorova discusses the use of troriluzole for spinocerebellar ataxia.  Show citations:       

info_outline
The Current State of Diagnostics for Neuroimmunologic Disorders in Africa show art The Current State of Diagnostics for Neuroimmunologic Disorders in Africa

Neurology Minute

Drs. Paul Crane, Fiifi Duodu, and Malya Sahu discuss neuroimmunology and multiple sclerosis diagnosis in Africa, including challenges and efforts to improve care.  Show citation:  Sahu M, Chomba M, Duodu F, Diaz MM, Sokhi D, Saylor D. The Current State of Diagnostics for Neuroimmunological Disorders in Africa. J Cent Nerv Syst Dis. 2025;17:11795735251385319. Published 2025 Nov 19. doi: 

info_outline
Ampreloxetine for Neurogenic Orthostatic Hypotension in MSA show art Ampreloxetine for Neurogenic Orthostatic Hypotension in MSA

Neurology Minute

Dr. Elizabeth Coon and Dr. Lucy Norcliffe-Kaufmann discuss the mechanism-based therapy with ampreloxetine for neurogenic orthostatic hypotension in multiple system atrophy, highlighting recent clinical trial results and future directions.  Show citation:  Freeman R, Kaufmann H, Biaggioni I, et al. Mechanism-Based Therapy With Ampreloxetine for Neurogenic Orthostatic Hypotension in Multiple System Atrophy: A Randomized Withdrawal Trial. Neurology. 2026;107(3):e218284. doi: 

info_outline
Sex Differences in Levodopa Pharmacokinetics in Early Parkinson Disease show art Sex Differences in Levodopa Pharmacokinetics in Early Parkinson Disease

Neurology Minute

Dr. Margarita Fedorova explores sex-related differences in the pharmacokinetics of levodopa among levodopa-naïve patients with PD and evaluates their relationships with levodopa-related complications. Show citation:  Conti V, De Bellis E, Corbi G, et al. Sex differences in levodopa pharmacokinetics in early Parkinson's disease: implications on levodopa-related complications. Front Pharmacol. 2026;17:1748932. Published 2026 Apr 7. doi: 

info_outline
Psychiatric Comorbidities in Epilepsy - Part 2 show art Psychiatric Comorbidities in Epilepsy - Part 2

Neurology Minute

In part two of this series, Dr. Halley Alexander and Dr. Heidi Munger Clary discuss the steps to take if you are screening for a psychiatric comorbidity and the results indicate that someone may be positive for depression, anxiety, or another condition.  Show citations:  Mula M, Brodie MJ, de Toffol B, et al. ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy. Epilepsia. 2022;63(2):316-334. doi:  Patel AD, Baca C, Franklin G, et al. Quality improvement in neurology: Epilepsy Quality Measurement Set 2017...

info_outline
August 2026 President Spotlight: How We’re Working with the AMA show art August 2026 President Spotlight: How We’re Working with the AMA

Neurology Minute

In the August episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost highlight how the AAN’s growing representation within the AMA strengthens the voice of neurology.  Stay informed by watching the .  

info_outline
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2 show art Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2

Neurology Minute

In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing  MS.  For more information, please read about the abstract that was presented at the .  Read more about the . 

info_outline
 
More Episodes

Dr. Alison Christy delves into another women's history minute to discuss Augusta Dejerine-Klumpke.